 | PRD_002560 | Name: | Entolysin A | Formula: | C81 H141 N17 O23 | Description: | D-Ser, L-Val, L-Leu, D-Ser, L-Ile amino acids make up a macrocycle within the peptide | Definition date: | 2025-02-26 | Last modified: | 2025-02-26 |
|
 | PRD_000695 | Name: | (2S)-1-[2-[(4-hydroxy-4-oxobutanoyl)amino]acetyl]pyrrolidine-2-carboxylic acid | Formula: | C11 H16 N2 O6 | Definition date: | 2024-08-07 | Last modified: | 2024-08-07 |
|
 | PRD_001025 | Name: | Trypsin inhibitor 1 | Formula: | C67 H107 N18 O19 S2 | Definition date: | 2013-10-09 | Last modified: | 2023-11-03 |
|
 | PRD_001107 | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | Formula: | C95 H147 N32 O21 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_001184 | Name: | Dimethyl FK228 | Formula: | C26 H42 N4 O6 S2 | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | Definition date: | 2014-03-05 | Last modified: | 2023-11-03 |
|
 | PRD_000555 | Name: | AERUGINOSIN 298-A | Formula: | C30 H48 N6 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_002285 | Name: | N~2~-[(2S)-2-{[3-(6-chloro-1,3-benzothiazol-2-yl)-N-propanoyl-L-alanyl]amino}-2-cyclopentylacetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-N~6~,N~6~-dimethyl-L-lysinamide | Formula: | C37 H49 Cl N6 O5 S | Definition date: | 2018-02-28 | Last modified: | 2023-11-03 |
|
 | PRD_002289 | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | Formula: | C68 H85 N13 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
 | PRD_002290 | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | Formula: | C69 H90 N13 O12 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
 | PRD_000846 | Name: | TRYPSIN INHIBITOR 1 | Formula: | C66 H106 N20 O18 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000154 | Name: | MINI-GRAMICIDIN A DIMER | Formula: | C168 H226 N32 O26 | Description: | THE N-TERMINI OF THE TWO IDENTICAL PEPTIDES, EACH
A TRUNCATED GRAMICIDIN A WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000155 | Name: | MINI-GRAMICIDIN A - GRAMICIDIN A DIMER | Formula: | C180 H244 N34 O30 | Description: | THE N-TERMINI OF THE TWO PEPTIDES, EACH A
TRUNCATED GRAMICIDIN A, WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000199 | Name: | Mersacidin | Formula: | C80 H120 N20 O21 S4 | Description: | MERSACIDIN IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION
OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO
DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE
CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES
DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR
RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000200 | Name: | Nisin A | Formula: | C141 H233 N41 O38 S7 | Description: | Nisin Z is a heptacyclic peptide. Post Translational maturation of
lantibiotics involves the enzymic conversion of Thr, and Ser into
dehydrated AA and the formation of thioether bonds with cysteine.
Thioether bonds with cysteine result in five cyclic structures along
the peptide chain. This is followed by membrane translocation and
cleavage of the modified precursor. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000272 | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | Formula: | C34 H50 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000298 | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | Formula: | C58 H72 N12 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000346 | Name: | N-{(2R)-3-phenyl-2-[(L-prolyl-L-threonyl-L-alpha-glutamyl)amino]propyl}-L-phenylalanyl-N~5~-[amino(iminio)methyl]-
L-ornithyl-L-glutamic acid | Formula: | C43 H63 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000399 | Name: | N-(3-carboxypropanoyl)-L-valyl-N-{(1R)-1-[(S)-hydroxy(oxido)phosphanyl]-2-phenylethyl}-L-prolinamide | Formula: | C22 H32 N3 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000414 | Name: | Meo-Suc-Ala-Ala-Pro-Val-chloromethyl ketone | Formula: | C22 H39 Cl N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000556 | Name: | AERUGINOSIN 98-B | Formula: | C29 H46 N6 O9 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000560 | Name: | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE | Formula: | C21 H31 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000696 | Name: | PSEUDOTYROSTATIN | Formula: | C23 H28 N2 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000705 | Name: | MICROGININ FR1 | Formula: | C38 H57 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000750 | Name: | CYCLIC KNOTTIN TRYPSIN INHIBITOR II | Formula: | C138 H229 N47 O45 S6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000756 | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1R)-5-amino-1-phosphonopentyl]-L-prolinamide | Formula: | C19 H35 N4 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|